Clinical Overview
Amoxycillin and Dicloxacillin is a dual bactericidal penicillin formulation engineered to conquer mixed bacterial infections. Amoxycillin inhibits bacterial cell wall synthesis across broad bacterial spectra, while dicloxacillin resists staphylococcal penicillinase degradation. Often formulated with Lactic Acid Bacillus to prevent disruption of gastrointestinal microbiota. Indicated for skin and soft tissue infections, wound sepsis, upper and lower respiratory infections, and post-surgical prophylaxis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally on an empty stomach (1 hour prior to food or 2 hours following a meal) with plenty of water. Do not lie down immediately after taking capsules to prevent esophageal irritation. Finish the entire course prescribed.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Nausea, indigestion, diarrhea, mild headache. Rare/Severe: Anaphylactic shock, hepatic dysfunction, interstitial nephritis, and Clostridioides difficile diarrhea.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in penicillin-hypersensitive individuals. Cross-allergenicity with cephalosporins may occur in up to 10% of sensitive patients. If severe or bloody diarrhea develops, seek medical consultation without taking anti-diarrheal motility blockers.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Amoxycillin 1g + Potassium Clavulanate 200mg Injection
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.
Amoxycillin 200mg + Potassium Clavulanate 28.5mg Oral Suspension per 5ml
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.
Amoxycillin 250mg + Potassium Clavulanate 50mg Injection
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.
Amoxycillin 500mg + Potassium Clavulanate 100mg Injection
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.